A significant discovery in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This vital cancer protector protein is frequently inactivated in various types of malignancies, https://webnowmedia.com/story7436435/mini-antibodies-revive-tumor-suppressor-p53-the-new-approach-for-tumor-management